RAREis Global Advocate Grant
We’re excited to share that we’ve been selected as a 2023 #RAREis Global Advocate Grant awardee by Horizon Therapeutics’ “RAREis” program. This award recognizes our contributions to advancing, educating, and addressing the needs of the rare disease community. With this support, we look forward to continuing to make a meaningful difference in the lives of everyone affected by spinal CSF leak.
For more information:
Learn more about the #RAREis Global Advocate Grant here.